DNAprint Genomics (DNAG)

[worktoplay]

There haven't been "press releases", but there clearly have been results. Here is just one example, ondansetron results, which were only recently presented at the annual meeting of the American Society of Anesthesiologists on October 15, 2006:

http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=C8F2EDAAE628B56E3A987BFE175...

In fact, far from Moffitt distancing themselves from DNAPrint, the "Discussion" contained in the abstract indicates that there will be further collaboration between the Moffitt and DNAPrint researchers with respect to ondansetron:

Discussion

Overall, our findings are consistent with previous reports for the incidence of PONV and response to treatment. We have found an association between SNPs and PONV that appear consistent with the pharmacology of the PONV triggering medications. All of the SNPs with p< 0.05 values will be tested in a validation study with independent subjects to identify which genes and SNP variants are predictors of PONV and the efficacy of Ondansetron.

I would also point out that this project wasn't even included in the original agreement, but was added for some reason. Tell me Doc, if the platform was not producing results in the originally intended areas, why would Moffitt expand it's use into other indications?

Thanks to mingwan0 for the link which he posted some time back on the Nap Heads II board.

Later,
W2P